Dr Nigel Burns joins Cell Medica
This article was originally published in Scrip
Cell Medica (UK) has named Dr Nigel Burns chairman. He has more than 20 years' experience in the biotech industry, most recently as a senior executive of Cambridge Antibody Technology. Cell Medica is a clinical-stage cellular therapeutics company engaged in the development and delivery of cellular immunotherapy treatment strategies for infectious disease.